Sign in
Join
Discovery/Preclinical
In vitro
In vivo
Newer Targets
Clinical
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Recall
Commercial
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Sign up
Welcome!
Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
Search
Sign in / Join
Contact
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Discovery/Preclinical
All
In vitro
In vivo
Newer Targets
Newer Targets
Hepion Pharmaceuticals’ CRV431 Prevents Cirrhosis in Experimental Model of Severe Liver…
Newer Targets
Palleon Pharmaceuticals to Present Preclinical Data on EAGLE-Her2 and Anti-Siglec-9 Antibody…
Newer Targets
Codiak Presents First Preclinical Data for exoASO, Engineered Exosomes Designed to…
Newer Targets
Nkarta Therapeutics Presents Preclinical Data for CD19 CAR NK Program
Clinical
All
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Recall
Approval
AstraZeneca’s Calquence Wins FDA Approval for Chronic Lymphocytic Leukemia
Phase III
First China-manufactured Trastuzumab Biosimilar HLX02 Global Phase III Trial Met Primary…
Phase II
Abivax Receives French Regulatory Authority (ANSM) Approval to Include French Study…
Approval
BRUKINSA (zanubrutinib) Approved for the Treatment of Mantle Cell Lymphoma, Available…
Commercial
All
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Deals
AbbVie and Harpoon Expand Partnership with $510 Million Licensing Deal
Acquisitions
Appili Therapeutics Acquires Clinical Stage Antifungal Program From FUJIFILM Toyama Chemical
Deals
Astellas and Welldoc Enter into Strategic Alliance for Digital Therapeutics
Commercial
Eli Lilly to Add 100 Employees Following $400 Million Manufacturing Investment
Home
Clinical
Phase II
Phase II
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Phase II
Abivax Receives French Regulatory Authority (ANSM) Approval to Include French Study Sites in its Phase 2b Ulcerative Colitis Clinical Trial and Provides a Progress...
Firstwordpharma News
-
November 21, 2019
Phase II
Foamix Announces Enrollment Completion of Phase 2 Acne Clinical Trial for FCD105 Minocycline 3% and Adapalene 0.3% Combination Foam
Phase II
Karuna Therapeutics Announces KarXT Met Primary Endpoint in Phase 2 Clinical Trial of Acute Psychosis in Patients with Schizophrenia
Phase II
Karuna Therapeutics Schedules Webcast and Conference Call to Announce Results from its Phase 2 Clinical Trial of KarXT for the Treatment of Psychosis in...
Phase II
VistaGen Reports Topline Phase 2 Results for AV-101 as an Adjunctive Treatment of Major Depressive Disorder
Phase II
Cassiopea Announces First Patient to be Enrolled in Phase II Trial...
Biospace News
-
November 13, 2019
0
Phase II
Aptinyx Initiates Two Phase 2 Studies of NYX-2925 in Patients with...
Biospace News
-
November 12, 2019
0
Phase II
Faraday Pharmaceuticals Announces Presentation of Clinical Data from Phase 2 Trial...
Biospace News
-
November 12, 2019
0
Phase II
Aerie Pharmaceuticals Announces Positive Topline Results for Netarsudil Ophthalmic Solution in...
Biospace News
-
November 5, 2019
0
Phase II
Paratek Announces Top Line Results of Phase 2 Clinical Studies of...
Firstwordpharma News
-
October 31, 2019
0
1
2
3
...
21
Page 1 of 21
- Advertisement -
MOST POPULAR
Infections Are Common in Patients Receiving Immune Checkpoint Inhibitors: Presented at...
March 5, 2019
Novo Nordisk Snags FDA Approval for Hemophilia A Treatment
February 20, 2019
AmerisourceBergen Reports Fiscal 2019 First Quarter Results
January 31, 2019
Pharmascience Inc. launches (Pr)pms-PROGESTERONE 200 mg capsule indicated as an adjunct...
March 29, 2019
Load more
HOT NEWS
Others
New Pharma Invention Index Picks AstraZeneca as Top Company
Others
Chugai Renews License to EpiVax’s ISPRI In Silico Toolkit for Immunogenicity...
Commercial
Biogen Loses $18B in Value as It Kills Aducanumab Alzheimer’s Program
Commercial
Merck to Hold Second-Quarter 2019 Sales and Earnings Conference Call on...
